CSF3 and neutropenia: In contrast, acquired truncating mutations in the cytoplasmatic region of the G-CSF receptor do not lead to neutropenia, but rather present a risk factor for the development of leukemia in patients with SCN, most likely due to hyper-responsiveness of selected clones to G-CSF (19, 20).